Program Schedule - TB Clinical Intensive – November 19-20, 2013
Tuesday, November 19, 2013
7:45 AM
Registration & Sign-In
8:15AM
Welcome and Introductions
Zelalem Temesgen, M.D., John Wilson, M.D., Stacey
Rizza, M.D.
Pre-Test
Epidemiology of Tuberculosis
Deb Sodt, R.N., P.H.N., M.P.H.
UAN: 0853-0000-018-L01-P
Contact Hours: .75
Objectives:
• Describe the TB epidemic in terms of
susceptible groups
• Describe major factors that will affect future
trends in TB
• Describe how HIV plays an important role in
the epidemiology of TB
8:30AM
8:45AM
9:30AM
10:15AM
10:30AM
11:15AM
TB Pathogenesis
Stacey Rizza, M.D.
UAN: 0853-0000-13-019-L01-P
Contact Hours: .75
Objectives:
 Explain how M. tuberculosis is transmitted
 Describe the pathogenesis of M. tuberculosis
 Explain how drug-resistant TB disease develops
Break
Infection Control
Priya Sampathkumar, M.D.
UAN: 0853-0000-13-020-L01-P
Objectives:
 Describe the components of an effective
infection control program
 Explain administrative, engineering controls,
and respiratory protection
 Describe ways healthcare workers can protect
themselves and others from being infected with
M. tuberculosis
Testing for TB Infection and Disease
Joshua Jones, M.D.
UAN: 0853-0000-13-023-L01-P
Contact Hours: .75
Objectives:
 Describe targeted testing strategies
 Explain how to interpret interferon-gamma

12:00PM
1:15 PM
2:00PM
2:45 PM
3:00PM
release assay (IGRA) results
Describe the differences between IGRAs and
the TST
Lunch
Advances in Laboratory TB Diagnosis
Nancy Wengenack, Ph.D.
UAN: 0853-0000-13-021-L01-P
Contact Hours: .75
Objectives:
 Describe laboratory methods used for the
detection, identification, genotyping, and drug
susceptibility testing of M. tuberculosis
Treatment of Latent TB Infection
Timothy Aksamit, M.D.
UAN: 0853-0000-13-022-L01-P
Contact Hours: .75
Objectives:
 Describe the current guidelines for LTBI
treatment
 Describe monitoring recommendations for
patients on LTBI treatment
 Explain management strategies for TB patients
with co-morbid conditions (e.g., HIV/AIDS)
 Explain treatment and management strategies
for certain populations (e.g., children)
Break
Treatment of TB Infection
Jennifer Whitaker, M.D.
UAN: 0853-0000-13-024-L01-P
Objectives:
 Describe the current guidelines for the treatment
of TB disease
 Describe the common adverse reactions to TB
treatment regimens
 Explain how to manage adverse reactions to TB
treatment regimens
3:45PM
Clinical Case Discussion
Kiran Belani, M.D.
UAN: 0853-0000-13-025-L01-P
Contact Hours: 1
Objectives:
• Demonstrate transfer of knowledge of
tuberculosis testing, diagnosis, and treatment to
a clinical case.
4:45PM
Adjourn
Wednesday, November 20,
2013
8:00 AM
Sign-in
8:30AM
Review / Q & A
Zelalem Temesgen, M.D., John Wilson, M.D., Stacey
Rizza, M.D.
Managing Adverse Drug Reactions
Dean Tsukayama, M.D.
UAN: 0853-0000-13-026-L01-P
Contact Hours: .75
Objectives:
 Describe the common adverse reactions to TB
treatment regimens
 Explain how to manage adverse reactions to TB
treatment regimens
Management of Drug Resistant TB
John Wilson, M.D.
UAN: 0853-0000-13-026-L01-P
Contact Hours: .75
Objectives:
-Describe factors responsible for delayed
response and/or treatment failure
-Describe treatment and management strategies
for multidrug-resistant TB
Break
Management of TB in Children and Adolescents
Ritu Banerjee, M.D., Ph.D.
UAN: 0853-0000-13-028-L01-P
Contact Hours: .75
Objectives:
• Describe the epidemiology of pediatric TB in
the US
• Describe the clinical presentation of TB in
children
• Describe treatment regimens for pediatric LTBI
and active TB
Lunch
TB/HIV Co-Infection
Zelalem Temesgen, M.D.
UAN: 0853-0000-13-029-L01-P
Contact Hours: .5
Objectives:
• Describe the epidemiology of TB/HIV coinfection
• Describe clinical presentation of TB disease in
populations with HIV
• Explain treatment and management strategies
8:45AM
9:30AM
10:15AM
10:30 AM
11:15AM
12:45PM
1:15 PM
2:00 PM
2:15PM
3:00PM
4:00PM
4:15PM
4:30
for TB patients with HIV.
TB and Correctional Facilities
Michael Nelson, D.O.
UAN: 0853-0000-13-030-L01-P
Contact Hours: .75
Objectives:
• Explain the differences in TB epidemiology
between correctional facilities and the US
general population
• Describe an outbreak contact investigation to
illustrate both the problems of, and
opportunities for, the prevention and control of
tuberculosis in correctional facilities
Break
Case Management
Judith B. Thomas, R.N., Shea Rabley, R.N.
UAN: 0853-0000-13-031-L01-P
Contact Hours: .75
Objectives:
 List basic epidemiology tools for TB case
management
 List the three steps of laboratory examination
necessary for adequate TB case management
 List four basic principles for the medical
management of TB cases
 List the primary components of the TB case
management model
Clinical Case Discussion
Ritu Banerjee, M.D., Ph.D.
UAN: 0853-0000-13-032-L01-P
Contact Hours: 1
Objectives:
• Demonstrate transfer of knowledge of
tuberculosis testing, diagnosis, and treatment to
a clinical case.
TB Resource Review
Jennifer Curran
UAN: 0853-0000-13-033-L01-P
Contact Hours: .25
Objectives:
 Identify the TB resources available for health
care professionals.
Post-test and Evaluation
Adjourn